Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With MET Exon 14-Mutant NSCLC

JTO Clin Res Rep. 2020 Jul 1;1(4):100072. doi: 10.1016/j.jtocrr.2020.100072. eCollection 2020 Nov.

Affiliations

¹ Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
² Department of Radiology, Brigham and Women's Hospital and Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

No abstract available

Publication types

Case Reports

Grants and funding

R01 CA203636/CA/NCI NIH HHS/United States